This topic contains a solution. Click here to go to the answer

Author Question: Progress and interim reports ________. A) discuss the day-to-day operations of a company B) ... (Read 145 times)

jman1234

  • Hero Member
  • *****
  • Posts: 560
Progress and interim reports ________.
 A) discuss the day-to-day operations of a company
  B) describe the status of continuing projects
  C) provide conclusions based on the data provided
  D) explain the benefits of a recommendation

Question 2

Trip, convention, and conference reports ________.
 A) help organizations know that their money was well spent in funding the travel
  B) inform management about new procedures, equipment, and laws
  C) supply information affecting products, operations, and service
  D) do all of these.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jaykayy05

  • Sr. Member
  • ****
  • Posts: 329
Answer to Question 1

B

Answer to Question 2

D




jman1234

  • Member
  • Posts: 560
Reply 2 on: Jun 23, 2018
Great answer, keep it coming :)


FergA

  • Member
  • Posts: 352
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

Many medications that are used to treat infertility are injected subcutaneously. This is easy to do using the anterior abdomen as the site of injection but avoiding the area directly around the belly button.

Did you know?

It is believed that humans initially contracted crabs from gorillas about 3 million years ago from either sleeping in gorilla nests or eating the apes.

Did you know?

More than 150,000 Americans killed by cardiovascular disease are younger than the age of 65 years.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library